. . . . . . . . . . . . . . . "kin(p(PFH:\"MAPK p38 Family\")) -> r(HGNC:HBEGF)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Pretreatment of NHBECs with the MEK-1 inhibitor PD98059 abolished the V2O5-induced increase in HB-EGF mRNA expression, whereas pretreatment with the p38 MAP kinase inhibitor SB203580 blocked the V2O5-induced increase in HB-EGF mRNA by ~ 80% (Figure 8 )." . . "Selventa" . . . . "2014-07-03T14:29:53.989+02:00"^^ . . .